EUDA Health Regains Nasdaq Compliance, Resolving Market Value Deficiency
EUDA has more than doubled off its 52-week low of $5.26.
Summary
EUDA Health has regained compliance with Nasdaq's minimum market value requirement, effectively resolving the delisting threat. This positive development follows a notice of non-compliance received on April 27th, which cited a deficiency in maintaining the $35 million minimum market value of listed securities. Resolving this issue removes a significant overhang and stabilizes the company's public market status.
At the time of this announcement, EUDA was trading at $18.06 on NASDAQ in the Technology sector, with a market capitalization of approximately $45M. The 52-week trading range was $5.26 to $86.00. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Dow Jones Newswires.